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A NEW ANTI-EMETIC FOR MUSTINE AUSEA*
R. SULY, M.A., M.MED. (RAn. T.), F.F.R. 10 H. S. KING, M.B., CH.B., Radiotherapy Department, emote SchulIr
Hospital and University of Cape Town
'I)ale received: 21 ovember 1968.
The over-all cure rate in the 35 cas followed up for more
than 3 years i 0·7% and the corrected cure rate i 9·7')\,. The
corrected ure rate for all 65 cas i 9·1 %.
Recent research on the problems of urinary tre in-
continence and bladder phy iology i briefly reviewed. Evidence,
both from the literature and from clinical practi e, lead to
the conclu ion that in the en urance of urinary continence two
separate factors are involved, viz., involuntary and voluntary
control mechanisms.
With regard to ati fa tory involuntary control the follow-
ing demands must be complied with: (0) for the Law of
Laplace to function, a hollow elastic tube--and not a funnel
-must be attached to a phere; (b) hould the adequate
approximation of muco al folds at the urethrove ical junction
be of importance (as it well may be), a urethra of small
enough diameter mu t be attached to the bladder. Both these
demands are met by ensuring the integrity of the fibrosal
'collar' surrounding the urethrovesical junction.
Concerning satisfactory voluntary control-the lesser prob-
lem-this is dependent on adequate function of the triated
muscle in the urogenital diaphragm.
An improvement in the over-all results following on urgical
treatment can only be obtained with full awarene s of the
aetiology, and with selective and correct implementation of
operative procedures.
I wish to thank Mis E. Andrews, medical artist, Johan-
nesburg, for the illustrations. This paper was ba ed on a thesis
for the degree of Master of Surgery in the University of the
Witwatersrand.
While a considerable amount of attention has been given
to the treatment of radiation sickness, surpri ingly little
has been given to that following alkylating and other
chemotherapeutic agents for cancer. The symptoms of
nausea and vomiting following treatment by the e means
can often be profound and cause the patient con iderable
mental and physical distress.
These symptoms are one of the factors which have to
be considered when prescribing therapy of this kind, and
has in our experience sometimes led to refusal of treat-
ment by patients. Moreover, since this type of therapy
is often symptomatic or palliative, the alleviation of
nausea and vomiting would take treatment of this kind
nearer the ideal cancer palliative--Ioss of symptoms with-
out causation of symptoms.
We have habitually treated mustine nausea by premedi-
cation with odium gardenal and have found this to be
fairly effective, provided the patient could sleep after-
wards, but it is less effective when used in the outpatient
treatment of mustine sickness. Many patients seem to
prefer outpatient therapy provided an early return to
their homes is possible after the injection, since thi causes
les disruption and home surrounding are nearly always
preferable to hospitalization.
Stoll1 found phenothiazines to be mo t effective in the
treatment of radiation sickne , and it i well known that
these drugs act by depressing the superficially situated







































the dor al portion of the lateral reticular formation in the
medulla.'
Apomorphine' and the emetic action of radiation' exert
their actions via this zone. It may be, however, that the
ite of action of nitrogen mustard in the induction of
vomiting is on the gut as well as centrally,' since it ha
been found with mas ive dose in cats that ablation of the
chemoreceptor zone with and without gut denervation did
not prevent vomiting. Further work i indicated here
since elucidation of this point, using clinical dosage levels,
would be of importance in further consideration of the
treatment of mustine nausea.
'Preclinical information supplied by manufacturers.
COI'ITROLLED TRIAL
A new phenothiazine derivative, 9965 RP, with the chemi-
cal formula of 2 methyl sulphonyl- 10 - 3'- (4 carbamoyl
piperidino) propyl phenothiazine, has been te ted. Thi
agent ha a very low toxicity and ha been hown to be
between 100 and 250 times more effective in preventing
apomorphine-induced vomiting in dogs than chlorproma-
zine. There is no effect on the vomiting induced by
installation of copper ulphate solution into the tomach
and it seems to exert its effects entirely by a central action.
Under laboratory condition the blood pres ure changes
are imilar in degree to tho e een with chlorpromazine
and there is a high anti erotonin effect.* Drow ines ha'
been noted in other evaluation of the drug, but no ide-
effects of any kind have been noted in our patient
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TABLE I. DIAG OSI OF DISEASES TREATED WITH MUSTI E
AND 9965 RP
One week later the patient was questioned by one of
us, who scored the degree of nausea and vomiting as as-
essed by the patient after the two injections. Four
degrees of se erity were recorded, i.e. severe, moderate,
mild and none. The: e corresponded to marked vomiting,
vomiting, nausea only and no symptoms. Respective scoring
values of 3 - 0 were given. The individually recorded re ult
were scored by a third person who had no contact with the
patient. For a result to be regarded as significant, it wa
required that there be at least a scoring difference of two
ince 9965 RP is one of the mo t powerful anti-emetic
known, it eemed that a controlled trial of this agent wa
indicated in mustine-induced nau ea. All 3 patient
taking part in the trial had confirmed malignant di ea e
with a limited life expectancy and required palliation of
ymptom.
Tho e who already had nausea and vomiting were ex-
cluded. The diagno e of the patient treated are hown in
Table 1. There were 29 male and 9 female in the trial,
with age ranging from 17 to 81 year. The two agent to
be te ted were prepared in ampoule containing 5 mg. of
9965 RP and 200 mg. of odium gardenal, respectively, and
were randomly allotted or B designation. Two in-
jection of mu tine, each 0·2 mg. / kg. body-weight, were
given on 2 ucce ive day, and the contents of one of the
erie of ampoules (A or B) were given intramuscularly at



















between the value given by the patients.
Of the 3 patient taking part in the trial, 19 howed
no preference for either compound, 15 preferred 996-
RP and 4 preferred odium gardenal. The re ults were
plotted by equential analy is and the new compound i
favoured (2a = 0'2).
DJ CUS IO
It is perhaps a little disappointing that 50% of tho e in
the trial returned a 'no preference' re ult, but it i to be
noted that out of the 76 mustine IOJection nearly half
(3 I) were followed by no (J 5) or mild (16) ymptom, and
6 patients did not vomit with either drug. However, 13
patients with moderate or evere ymptoms failed to show
any preference. The possible explanation for this might
be a peripheral action of mustine, apart from a po sible
failure of central control. We nevertheless consider thi
new agent to be of value, and it is to be preferred to
sodium gardenal and to chlorpromazine. It would be
intere ting to compare its efficacy with that of trifluopera-
zine (Stelazine) which wa found by Stoll' to be one of
the more effective agents for the relief of radiation
nausea.
SUM IARY
A clinical trial comparing the efficiency of odium gardenal
and a new phenothiazine derivative in mustine nausea has been
undertaken. The new compound is favoured. Some aspects of
radiation and chemotherapy nausea are discussed.
We wish to thank Dr J. G. Burger, Medical Superintendent
of Groote Schuur Hospital, for permission to publish; May-
baker (S.A.) Pty Lld for the supply of the agents used; and
Mr R. L. Capell, without whose assistance this trial would not
have been possible.
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MY EXPERIE CE AS A HEALTH EDUCATOR IN A BANTU TUBERCUWSIS HOSPITAL*
P. MGOBOZI, Health Educator, East Rand Santa Centre, Madder 'B', Transvaal
Tuberculo is constitutes a major public health problem in
South Africa. Owing to ignorance, patients often do not
come for treatment in the early stages of the disease, nor
do they attend regularly for the prolonged treatment neces-
sary once they have been diagnosed. Therefore the South
African ational Tuberculosis Association (SANTA) has
embarked on a programme of appointing health educators
to work with Bantu patients. I am such a health educator.
Magic and superstition form the central core of the
Bantu view on the causation of disease. It is only through
education that scientific concepts will gradually replace
magico-religious systems of thought and thus modify
people' beha iour in relation to di ease.
'Date received: 2 June 1969.
fATERIAL AND METHODS
I am employed full-time at the East Rand Santa Centre,
Modder 'B', where there are 750 beds, all for Bantu.
1 conduct both private interviews and group sessions and
try to meet every patient soon after admission to the Santa
Centre, and prepare him or her for prolonged stay in
hospital. 1 try to help them adopt a positive outlook to-
wards their illness. Also,'1 try to meet every patient about
to be discharged and re-emphasize the importance of pro-
longed outpatient therapy.
While the patients are in hospital, I meet them in groups,
which may be organized by me or el e arise spontaneously.
Free di cussion is encouraged at these meeting and every
patient i allowed to tate his or her view, however ho tile
